Non-Current Liabilities
Convertible Debt (Non-Current)
Guardant Health Convertible Debt (Non-Current) decreased by 0.0% to $1.5B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.7%, from $1.12B to $1.5B. Over 5 years (FY 2020 to FY 2025), Convertible Debt (Non-Current) shows an upward trend with a 13.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 7, 2026
How to read this metric
High levels indicate reliance on convertible financing, which may lead to shareholder dilution upon conversion.
Detailed definition
This represents the portion of debt that can be converted into equity, with a maturity date extending beyond one year. I...
Peer comparison
Common in high-growth biotech and tech sectors; evaluated based on conversion price and maturity timing.
Metric ID:
convertible_debt_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.13B | $1.13B | $1.13B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.12B | $1.12B | $1.11B | $1.5B | $1.5B |
| QoQ Change | — | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | -2.3% | -0.1% | -0.1% | +34.9% | -0.0% |
| YoY Change | — | — | — | — | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | -2.1% | -2.3% | -2.4% | +31.6% | +34.7% |
Range$1.11B – $1.5B
CAGR+6.1%
Avg YoY Growth+3.9%
Median YoY Growth+0.2%
Convertible Debt (Non-Current) at Other Companies
Frequently Asked Questions
- What is Guardant Health's convertible debt (non-current)?
- Guardant Health (GH) reported convertible debt (non-current) of $1.5B in Q1 2026.
- How has Guardant Health's convertible debt (non-current) changed year-over-year?
- Guardant Health's convertible debt (non-current) increased by 34.7% year-over-year, from $1.12B to $1.5B.
- What is the long-term trend for Guardant Health's convertible debt (non-current)?
- Over 5 years (2020 to 2025), Guardant Health's convertible debt (non-current) has grown at a 13.3% compound annual growth rate (CAGR), from $806.29M to $1.5B.
- What does convertible debt (non-current) mean?
- Long-term debt that can be swapped for company stock at a later date.